[How is antianginal therapy with pentaerythritol tetranitrate executed?].
Schneider
Christian A
CA
Klinik III für Innere Medizin, Köln, Germany. Erland.Erdmann@uni-koeln.de
D000787:Angina Pectoris / Q000188:drug therapy*; D000818:Animals; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D007548:Isosorbide Dinitrate / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010417:Pentaerythritol Tetranitrate / Q000627:therapeutic use*; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D014665:Vasodilator Agents; D010417:Pentaerythritol Tetranitrate; D007548:Isosorbide Dinitrate; C030397:isosorbide-5-mononitrate